Prognostic value of the fibrinogen/albumin ratio (FAR) in patients with operable soft tissue sarcoma

[1]  Wei Wang,et al.  Combined Use of the Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as a Prognostic Predictor in Patients with Operable Soft Tissue Sarcoma , 2018, Journal of Cancer.

[2]  Ying Zhu,et al.  Prognostic value of systemic inflammatory markers in ovarian Cancer: a PRISMA-compliant meta-analysis and systematic review , 2018, BMC cancer.

[3]  Yutong He,et al.  The prognostic value of neutrophil to lymphocyte and platelet to lymphocyte ratios for patients with lung cancer , 2017, Oncology letters.

[4]  A. Yoshizawa,et al.  Clinical significance of preoperative serum albumin level for prognosis in surgically resected patients with non-small cell lung cancer: Comparative study of normal lung, emphysema, and pulmonary fibrosis , 2017 .

[5]  H. Toh,et al.  Awakening immunity against cancer: a 2017 primer for clinicians , 2017, Chinese journal of cancer.

[6]  Jiwei Huang,et al.  Association of post-treatment hypoalbuminemia and survival in Chinese patients with metastatic renal cell carcinoma , 2017, Chinese journal of cancer.

[7]  Hong Yang,et al.  A novel blood tool of cancer prognosis in esophageal squamous cell carcinoma: the Fibrinogen/Albumin Ratio , 2017, Journal of Cancer.

[8]  I. Judson,et al.  Soft tissue sarcomas in adolescents and young adults: a comparison with their paediatric and adult counterparts. , 2017, The Lancet. Oncology.

[9]  Daisuke Kawahara,et al.  Prognostic significance of preoperative inflammatory response biomarkers in patients undergoing curative thoracoscopic esophagectomy for esophageal squamous cell carcinoma. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[10]  H. Kemona,et al.  From inflammation to cancer , 2016, Irish Journal of Medical Science (1971 -).

[11]  M. Sharma,et al.  Prognostic factors affecting survival in metastatic soft tissue sarcoma: an analysis of 110 patients , 2016, Clinical and Translational Oncology.

[12]  Deqing Liu,et al.  Cumulative scores based on plasma D-dimer and serum albumin levels predict survival in esophageal squamous cell carcinoma patients treated with transthoracic esophagectomy , 2016, Chinese journal of cancer.

[13]  G. Heinze,et al.  Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysis. , 2015, Cancer treatment reviews.

[14]  Y. Tajima,et al.  Impact of inflammation-based prognostic score on survival after curative thoracoscopic esophagectomy for esophageal cancer. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[15]  H. Samonigg,et al.  Pre-Treatment Anemia Is a Poor Prognostic Factor in Soft Tissue Sarcoma Patients , 2014, PloS one.

[16]  K. Van Loon,et al.  Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab: A pooled analysis of 7 prospective trials of gemcitabine‐based therapy with or without bevacizumab , 2014, Cancer.

[17]  Khin Thway,et al.  Systemic treatment of soft-tissue sarcoma—gold standard and novel therapies , 2014, Nature Reviews Clinical Oncology.

[18]  H. Samonigg,et al.  The elevated pre‐operative plasma fibrinogen level is an independent negative prognostic factor for cancer‐specific, disease‐free and overall survival in soft‐tissue sarcoma patients , 2014, Journal of surgical oncology.

[19]  F. Chibon,et al.  Grading of soft tissue sarcomas: from histological to molecular assessment. , 2014, Pathology.

[20]  C. Fletcher,et al.  WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition , 2014, Pathology.

[21]  D. Su,et al.  Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer , 2013, International journal of cancer.

[22]  K. Pummer,et al.  High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients , 2013, British Journal of Cancer.

[23]  Adrian Ranga,et al.  Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix , 2013, Proceedings of the National Academy of Sciences.

[24]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[25]  S. Hao,et al.  Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity , 2009, Cancer science.

[26]  L. Koniaris,et al.  Outcomes for soft-tissue sarcoma in 8249 cases from a large state cancer registry. , 2007, The Journal of surgical research.

[27]  P. Sandset,et al.  Fibrinogen and fibrin induce synthesis of proinflammatory cytokines from isolated peripheral blood mononuclear cells , 2007, Thrombosis and Haemostasis.

[28]  R. Pollock,et al.  Soft Tissue Sarcomas , 2001, CA: a cancer journal for clinicians.

[29]  J. Cohen,et al.  The 150 most important questions in cancer research and clinical oncology series: Questions 31-39 , 2017 .

[30]  A. Sudo,et al.  Impact of plasma fibrinogen levels in benign and malignant soft tissue tumors. , 2016, Cancer Biomarkers.

[31]  T. Omori,et al.  Cumulative Prognostic Scores Based on Plasma Fibrinogen and Serum Albumin Levels in Esophageal Cancer Patients Treated with Transthoracic Esophagectomy: Comparison with the Glasgow Prognostic Score , 2014, Annals of Surgical Oncology.

[32]  York Springer,et al.  Ajcc Cancer Staging Manual. 7th Ed. New , 2010 .

[33]  David A. Cheresh,et al.  Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.

[34]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[35]  J. Cooper.  Ajcc Cancer Staging Manual , 1997 .